Nanosonics | NAN - 净收入



金融业
股票价格
AUD
资产
AUD 279.25M
现金及等价物
AUD 161.29M
销售成本
AUD 24.23M
流动资产
AUD 234.13M
流动负债
AUD 36.59M
债务
AUD 7.69M
EBIT
AUD 9.12M
EBITDA
AUD 12.49M
员工
470
EPS每股收益
AUD 0.03
股本和储备
AUD 219.69M
销售毛利
AUD 78.01M
债务利息支出
AUD 779K
利息收入
AUD 2.89M
贷款资金
AUD 3.21M
市值
AUD 836M
净收入
AUD 9.64M
营业费用
AUD 93.11M
营业利润
AUD 9.12M
普通股股本
AUD 303.35M
PE价格收益
65.33
税前利润
AUD 11.39M
销售收入
AUD 102.23M
销售和管理费用
AUD 53.78M
股票
AUD 18.63M
贸易债权人
AUD 12.22M
应收帐款人
AUD 46.45M


净收入 更改 日
Alcidion AUD 1.33M 1.21M 2025-12
Ansell USD 88.8M 65.5M 2025-12
Avita Medical AUD -11.62M 1.7M 2025-12
Cochlear AUD 161.5M 69.6M 2025-12
CSL USD 401M 96.5M 2025-12
Fisher & Paykel Healthcare NZD 255.5M 42.5M 2026-06
Healius AUD -12.8M 7.8M 2024-12
Integral Diagnostics AUD 6.06M 72.81M 2024-06
Mayne Pharma AUD -103.68M 68.4M 2024-06
Polynovo AUD 3K 9.87M 2025-12
Pro Medicus AUD 94.12M 77.1M 2026-06
Ramsay Health Care AUD 152.7M 32.4M 2025-12
ResMed USD 398.73M 6.14M 2026-03
Somnomed AUD -4.25M 509.26K 2023-06
Sonic Healthcare AUD 236.68M 82.29M 2024-12